
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:og="http://opengraphprotocol.org/schema/">
	<head><title>
	Why I Bought Exelixis (EXEL)
</title><meta http-equiv="Content-Type" content="text/html;charset=utf-8" /><meta property="fb:app_id" content="50808187550" />
	<meta http-equiv="imagetoolbar" content="no" />
	
	
	<link rel="image_src" href="http://g.foolcdn.com/art/facebook/FBdefault.png" />
    
    <script src="//cdn.optimizely.com/js/377930436.js"></script>
	
	
	<link rel="alternate" type="application/rss+xml" href="http://www.fool.com/feeds/index.aspx?id=foolwatch&format=rss2" />
    <link href="https://plus.google.com/100085898295463832129" rel="publisher"/>
	
	
	<link rel="canonical" href="http://www.fool.com/investing/general/2014/04/04/why-i-bought-exelixis.aspx" />

    
    
     <meta name='parsely-page' content='{
  "title": "Why I Bought Exelixis",
  "link": "http://www.fool.com/investing/general/2014/04/04/why-i-bought-exelixis.aspx",
  "image_url": "",
  "type": "post",
  "post_id": "aeb9b062-b9ef-11e3-9564-0050569d32b9",
  "pub_date": "2014-04-04T16:05:00Z",
  "section": "Health Care",
  "author": "Sean Williams"
}' />
    


<link href="http://s.foolcdn.com/common/css/fool.css?v=82515" rel="stylesheet" type="text/css" media="all" /><link href="http://s.foolcdn.com/common/css/Bridge.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	<link href="http://s.foolcdn.com/common/css/Usmf.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	
	
	
	<link href="http://s.foolcdn.com/common/css/globalTickerHover.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	<link href="http://s.foolcdn.com/css/predictive-search-results.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	
	<link href="http://s.foolcdn.com/css/articlepage.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	<link href="http://s.foolcdn.com/css/Modules/mom.css?v=82515" rel="stylesheet" type="text/css" media="all" />
	<link href="http://s.foolcdn.com/css/main/todaysMarket.css?v=82515" rel="stylesheet" type="text/css" media="all" />



			<script type='text/javascript'>
			var isUserNameCreated = false;
			var isLoggedIn = false;
			var hasUserName = true;
			var isRegistered = false;
			</script><script src="http://j.foolcdn.com/common/js/prototype_fool.min.js?v=82515" type="text/javascript"></script>
			<script type="text/javascript">
			    var googletag = googletag || {};
			    googletag.cmd = googletag.cmd || [];
			    (function () {
			        var gads = document.createElement("script");
			        gads.async = true;
			        gads.type = "text/javascript";
			        var useSSL = "https:" == document.location.protocol;
			        gads.src = (useSSL ? "https:" : "http:") + "//www.googletagservices.com/tag/js/gpt.js";
			        var node = document.getElementsByTagName("script")[0];
			        node.parentNode.insertBefore(gads, node);
			    })();
            </script>
		
    <script language="javascript" type="text/javascript">
        dfp_email = '';
    </script>
 	<script src="http://j.foolcdn.com/common/js/fx_usmf.min.js?v=82515" type="text/javascript"></script>
	<!--[if IE 6]>
	<script src="http://j.foolcdn.com/common/js/DD_belatedPNG_0.0.8a.min.js" type="text/javascript"></script>
	<![endif]-->
	
	<script src="http://j.foolcdn.com/js/www_expando.min.js?v=82515" type="text/javascript"></script>
	
	<script src="http://j.foolcdn.com/js/article_recommendations.min.js?v=82515" type="text/javascript"></script>
	<script type="text/javascript">Article.prepare();</script>
	

    <script src="http://h.foolcdn.com/tmfstatic/js/vendor/jquery-1.7.2.min.js"></script>
    <script type="text/javascript">
        jQuery.noConflict();
    </script>
    <script src="http://s3.amazonaws.com/foolstatic/leadspend_validation.js"></script>

	
	
	<!-- Start Google Analytics -->
	<script type="text/javascript">
		var _gaq = _gaq || [];
		_gaq.push(['_setAccount', 'UA-3262475-1']);
		_gaq.push(['_setDomainName', 'fool.com']);
		_gaq.push(['_trackPageview']);

		(function() {
			var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
			ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
			var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
		})();
	</script>
	<!-- End Google Analytics -->


    <script type="text/javascript">
        var start = new Date();
        window.onbeforeunload = function () {
            try {
                var time = new Date() - start;
                time = Math.round(time / 1000);
                _gaq.push(['_trackEvent', 'PagePerf', 'OnUnload', time.toString()]);
            } catch (err) {
                //swallow errors here.
                return;
            }
        };
    </script>
<meta name="title" content="Why I Bought Exelixis" /><meta name="headline" content="Why I Bought Exelixis" /><meta name="STORY_UID" content="aeb9b062-b9ef-11e3-9564-0050569d32b9" /><meta name="author" content="Sean Williams" /><meta name="articletype" content="Investing" /><meta name="collection" content="Investing" /><meta name="date" content="2014-04-04T12:05:00-05:00" /><meta name="promo" content="The author shares his opinion why the recent drop in Exelixis is an incredible buying opportunity." /><meta name="description" content="The author shares his opinion why the recent drop in Exelixis is an incredible buying opportunity.  - Sean Williams - Health Care" /><meta name="bureau" content="health-care" /><meta name="gsa_date" content="2014-04-04" /><meta name="gsa_date" content="2014-04-04" /></head>
	
	<body id="ctl01_ctl00_ctl00_ctl00_ctl00_ctl00_cphContent_Body" class="hlp Default collectionInvesting">
	    <script type='text/javascript' src='/common/js/marketing/reqwest.min.js'></script>
	    <script type='text/javascript' src='/common/js/marketing/ads.js'></script>

	    

<script>
    dataLayer = [];
</script>
<!-- Google Tag Manager -->
<noscript>
    <iframe src="//www.googletagmanager.com/ns.html?id=GTM-HQ4K"
        height="0" width="0" style="display: none; visibility: hidden"></iframe>
</noscript>
<script>(function (w, d, s, l, i) {
    w[l] = w[l] || []; w[l].push({
        'gtm.start':
        new Date().getTime(), event: 'gtm.js'
    }); var f = d.getElementsByTagName(s)[0],
    j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
    '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
})(window, document, 'script', 'dataLayer', 'GTM-HQ4K');</script>
<!-- End Google Tag Manager -->

	    

<script type="text/javascript">
    (function (c, a) {
        window.mixpanel = a; var b, d, h, e; b = c.createElement("script");
        b.type = "text/javascript"; b.async = !0; b.src = ("https:" === c.location.protocol ? "https:" : "http:") +
        '//g.foolcdn.com/js/lib/mixpanel-2.2.min.js'; d = c.getElementsByTagName("script")[0];
        d.parentNode.insertBefore(b, d); a._i = []; a.init = function (b, c, f) {
            function d(a, b) {
                var c = b.split("."); 2 == c.length && (a = a[c[0]], b = c[1]); a[b] = function () {
                    a.push([b].concat(
                    Array.prototype.slice.call(arguments, 0)))
                }
            } var g = a; "undefined" !== typeof f ? g = a[f] = [] :
            f = "mixpanel"; g.people = g.people || []; h = ['disable', 'track', 'track_pageview', 'track_links',
            'track_forms', 'register', 'register_once', 'unregister', 'identify', 'alias', 'name_tag', 'set_config',
            'people.set', 'people.set_once', 'people.increment', 'people.track_charge', 'people.append'];
            for (e = 0; e < h.length; e++) d(g, h[e]); a._i.push([b, c, f])
        }; a.__SV = 1.2;
    })(document, window.mixpanel || []);
    
    mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");
    mixpanel.set_config({
        track_pageview: false
    });
</script>


		
		
	<div id="header" class="navCellA">
			
				
		   

<div id="tophat" class="clearfix">
  <div class="">
    <div id="tophatWrap">
	<div id="navigation" class="clearfix">
		<ul id="site-nav" class="site-nav-hide">
          <li class="countryIcon countryUSIcon"><a class="qs-source-iflsittph0000001 select" href="http://www.fool.com/">
					Fool.com
				</a></li>
          <li class="countryIcon countryGBIcon"><a class="qs-source-iflsittph0000001" href="http://www.fool.co.uk/">
					Fool.co.uk
				</a></li>
          <li class="countryIcon countryAUIcon"><a class="qs-source-iflsittph0000001" href="http://www.fool.com.au/">
					Fool.com.au
				</a></li>
          <li class="countryIcon countryCAIcon"><a class="qs-source-iflsittph0000001" href="http://www.fool.ca/">
					Fool.ca
				</a></li>
          <li class="countryIcon countrySGIcon"><a class="qs-source-iflsittph0000001" href="http://www.fool.sg">
					Fool.sg
				</a></li>
        </ul>
		<span id="quips">The World's Greatest Investing Community</span>
	</div>
	<div id="userTools">
		<span id="welcome">Welcome!</span>
		<ul id="premium" class="dropMenu">
          <li class="topLevel"><a href="/shop/newsletters/index.aspx" class="qsAdd qs-source-ipesittph0000001"><span><span>Premium Advice</span></span></a><ul id="premium-list">
              <li class="info subhead"><strong>My Services</strong></li>
              <li class="info">None</li>
              <li class="info subhead"><strong>Other Services</strong></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1255/">Fool One</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1008/">Hidden Gems</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1048/">Income Investor</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1066/">Inside Value</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1451/">MDP Deep Value</a></li>
              <li><a class="qsAdd qs-source-idpsithat0000002" href="http://newsletters.fool.com/30/">Million Dollar Portfolio</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/50/">Motley Fool Options</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1228/">Motley Fool Pro</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1069/">Rule Breakers</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/1062/">Rule Your Retirement</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/52/">Special Ops</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002" href="http://newsletters.fool.com/18/">Stock Advisor</a></li>
              <li><a class="qsAdd qs-source-ipesittph0000002 last" href="http://newsletters.fool.com/1502/">Supernova</a></li>
            </ul>
          </li>
        </ul>
			
		
		<span id="Help"><a class="qsAdd qs-source-ihesittph0000001" href="/help/index.htm">Help</a></span>
		<span id="join"><a class="qsAdd qs-source-ijnsittph0000001" href="/landing/tmf/secure/registration.aspx">Join Now</a></span>
		<span>or</span>
		<span id="login"><a class="qsAdd qs-source-ilgsittph0000001" href="https://www.fool.com/secure/login.aspx">Login</a></span>
	</div>
</div>
  </div><script type="text/javascript">Fool.Util.PseudoClass.hover('#tophatWrap li.topLevel');</script></div><div id="topnav"><div class="grid">
  <!--DO NOT REMOVE THIS TOPNAV COMMENT!-->
  <div id="logo"><a class="qsAdd qs-source-illsitima0000001" href="http://www.fool.com/">The Motley Fool
			</a></div>
  <form id="searchForm" method="get" action="/search/solr.aspx"><fieldset id="search"><input type="hidden" name="exchange-input" id="top_exchange_input" /><input autocomplete="off" class="query" value="Enter Keywords or Ticker" type="text" name="q" maxlength="100" /><input type="hidden" name="source" value="ignsittn0000001" /><input id="commandSearch" class="btn doSearch" type="submit" /></fieldset></form>
  <div id="menu" class="grid clearfix"><div class="column span-25"><ul class="clearfix">
    <li class="qsAdd qs-source-iflsittph0000001"><a href="http://www.fool.com/" class="qsAdd qs-source-iflsittph0000001"><span>Home</span></a>
      <ul>
        <li class="qsAdd qs-source-ifltnvsnv0000001 foolwatch"><a href="/foolwatch/foolwatch.aspx" class="qsAdd qs-source-ifltnvsnv0000001 foolwatch">All Fool Headlines</a></li>
        
				<li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://military.fool.com/" class="qsAdd qs-source-ifltnvsnv0000001">Fool Military</a></li>
				<li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/press/about.htm" class="last qsAdd qs-source-ifltnvsnv0000001">About The Motley Fool</a></li>
      </ul>
    </li>
    <li class="qsAdd qs-source-ipesittph0000001"><a href="http://my.fool.com/" class="qsAdd qs-source-ipesittph0000001"><span>My Fool</span></a>
      <ul>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="https://my.fool.com/Profile" class="qsAdd qs-source-ipesitlnk0000001">My Profile</a></li>
				<li class="qsAdd qs-source-ipesitlnk0000001"><a href="/myarticles" class="qsAdd qs-source-ipesitlnk0000001">My Articles</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://my.fool.com/watchlist" class="qsAdd qs-source-ipesitlnk0000001">My Watchlist</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001 premium"><a href="http://newsletters.fool.com/MyScorecard/MyScorecardRedirect.aspx" class="qsAdd qs-source-ipesitlnk0000001 premium">My Scorecard</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://boards.fool.com/FavoriteBoards.asp?" class="qsAdd qs-source-ipesitlnk0000001">My Boards</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://caps.fool.com/MyPlayer.aspx" class="qsAdd qs-source-ipesitlnk0000001">My CAPS</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://my.fool.com/#my-reports" class="qsAdd qs-source-ipesitlnk0000001">My Reports</a></li>
        <li class="last qsAdd qs-source-ipesitlnk0000001"><a href="https://www.fool.com/Account/Index.aspx" class="last qsAdd qs-source-ipesitlnk0000001">My Settings</a></li>
      </ul>
    </li>
    <li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/how-to-invest/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>How To Invest</span></a>
      <ul>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/how-to-invest/thirteen-steps/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">13 Steps</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/how-to-invest/broker/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Find a Broker</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://wiki.fool.com/" class="qsAdd qs-source-ifltnvsnv0000001">Investing Wiki</a></li>
        <li class=" last qsAdd qs-source-ifltnvsnv0000001"><a href="/how-to-invest/personal-finance/index.aspx" class=" last qsAdd qs-source-ifltnvsnv0000001">Personal Finance</a></li>
      </ul>
    </li>
    <li class="qsAdd qs-source-ifltnvpnv0000001 on"><a href="/investing/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>Investing Commentary</span></a>
      <ul>
        <li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/investing/basics/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001">Basics</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/etf/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">ETFs</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/options/options-a-foolish-introduction.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Options</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/small-cap/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Small-Cap</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/dividends-income/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Dividends &amp; Income</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/high-growth/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">High Growth</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/value/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Value</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/mutualfunds/mutualfunds.htm" class="qsAdd qs-source-ifltnvsnv0000001">Mutual Funds</a></li>
        <li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/investing/international/index.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">International</a></li>
      </ul>
    </li>
    <li class="capsTab qsAdd qs-source-ifltnvpnv0000001"><a href="http://caps.fool.com/index.aspx" class="capsTab qsAdd qs-source-ifltnvpnv0000001"><span>CAPS Community</span></a>
      <ul>
        <li class="capsHome qsAdd qs-source-icasitlnk0000006"><a href="http://caps.fool.com/" class="capsHome qsAdd qs-source-icasitlnk0000006">CAPS Home</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/" class="qsAdd qs-source-ifltnvsnv0000001">CAPS Home</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/MyPlayer.aspx" class="qsAdd qs-source-ifltnvsnv0000001">My CAPS</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/TickerRankings.aspx?filter=7&amp;sortcol=38&amp;sortdir=1" class="qsAdd qs-source-ifltnvsnv0000001">Stocks</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/Screener.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Screener</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/PlayerRankings.aspx?filter=20&amp;sortcol=5&amp;sortdir=1" class="qsAdd qs-source-ifltnvsnv0000001">Players</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/Blogs/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Blogs</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/Stats.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Top Tens</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/TagRankings.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Tags</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/Contests.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Contests</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/FeedBack.aspx" class="qsAdd qs-source-ifltnvsnv0000001">Contact Us</a></li>
        <li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="http://caps.fool.com/Help.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">Help</a></li>
      </ul>
    </li>
    <li class="qsAdd qs-source-ifltnvpnv0000001"><a href="/retirement/index.aspx" class="qsAdd qs-source-ifltnvpnv0000001"><span>Retirement</span></a>
      <ul>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/retirement/general/how-to-retire-in-style.aspx" class="qsAdd qs-source-ifltnvsnv0000001">13 Retirement Steps</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/retirement/ira/index.aspx" class="qsAdd qs-source-ifltnvsnv0000001">IRAs</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="/retirement/401k/401kintro-is-your-retirement-plan-foolish.aspx" class="qsAdd qs-source-ifltnvsnv0000001">401(k)s, Etc.</a></li>
        <li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="/retirement/assetallocation/introduction-to-asset-allocation.aspx" class="last qsAdd qs-source-ifltnvsnv0000001">Asset Allocation</a></li>
      </ul>
    </li>
    <li class="qsAdd qs-source-ifltnvpnv0000001"><a href="http://boards.fool.com/" class="qsAdd qs-source-ifltnvpnv0000001"><span>Boards</span></a>
      <ul>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://boards.fool.com/BestOf.asp" class="qsAdd qs-source-ifltnvsnv0000001">Best Of</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://boards.fool.com/favoriteboards.asp" class="qsAdd qs-source-ifltnvsnv0000001">Favorites &amp; Replies</a></li>
        <li class="qsAdd qs-source-ifltnvsnv0000001"><a href="http://boards.fool.com/EditFavoriteBoards.asp" class="qsAdd qs-source-ifltnvsnv0000001">Customize</a></li>
        <li class="last qsAdd qs-source-ifltnvsnv0000001"><a href="http://boards.fool.com/request.asp" class="last qsAdd qs-source-ifltnvsnv0000001">Start a New Board</a></li>
      </ul>
    </li>
    <li class="premium qsAdd qs-source-ipesittph0000001"><a href="/shop/newsletters/index.aspx" class="premium qsAdd qs-source-ipesittph0000001"><span>Fool Store</span></a>
      <ul>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://newsletters.fool.com/18/index.aspx" class="qsAdd qs-source-ipesitlnk0000001">Stock Advisor</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://newsletters.fool.com/04/index.aspx" class="qsAdd qs-source-ipesitlnk0000001">Hidden Gems</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://newsletters.fool.com/15/index.aspx" class="qsAdd qs-source-ipesitlnk0000001">Rule Breakers</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://newsletters.fool.com/30/index.aspx" class="qsAdd qs-source-ipesitlnk0000001">Million Dollar Portfolio</a></li>
        <li class="qsAdd qs-source-ipesitlnk0000001"><a href="http://newsletters.fool.com/1228/index.aspx" class="qsAdd qs-source-ipesitlnk0000001">Motley Fool PRO</a></li>
        <li class="last qsAdd qs-source-ipesitlnk0000001"><a href="http://app.fool.com/" class="last qsAdd qs-source-ipesitlnk0000001">Motley Fool Mobile</a></li>
      </ul>
    </li>
  </ul></div></div>
  <img width="0" height="0" class="vs-tracking-px" src="http://www.fool.com/tracking/vs/vs_track.gif?_rnd=500761964&amp;actual_url=http%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2014%2f04%2f04%2fwhy-i-bought-exelixis.aspx&amp;articletype=collection548&amp;author=Sean+Williams+&amp;authortype=author&amp;bureau=Health+Care&amp;CellID=3%2c1%2c0%2c0%2c1&amp;headline=Why+I+Bought+Exelixis&amp;log=1&amp;newsitetest=0&amp;referrer=http%3a%2f%2fnone%2f&amp;segment=default&amp;site=usmf.inv.investing&amp;storytype=Article&amp;TestID=ALPTemplate%2cYourMyMom%3a001%2cprmoCSS%3a01%2ctickleDesign%3a001%2cticklePersist%3a001&amp;uid=0&amp;url=http%3a%2f%2fwww.fool.com%2finvesting%2fgeneral%2f2014%2f04%2f04%2fwhy-i-bought-exelixis.aspx&amp;usmfRedirectCriteria=AlwaysTrue&amp;zone=articles" />
  
</div></div><script type="text/javascript">	var topNav = new Usmf.Tabs('menu'); topNav.insertSubnavElement('foolwatch', 'Motley Fool Funds', 'You are leaving Fool.com, operated by The Motley Fool, LLC.  Would you like to continue to FoolFunds.com, operated by Motley Fool Asset Management, LLC?', 'http://www.foolfunds.com'); new Fool.Util.SearchBox('searchForm');</script>
	</div>








		
	<div id="mid">
		<div class="grid">
			
	    <div id="flash">
		    
            
    

		    
		    
	    </div>

	    <div id="layout" class="bigBox round clearfix">
				
					
		    
		    
            <script type="text/javascript">
                var element = document.getElementById("myWatchlistModuleContainer");
                if (element != null)
                    element.parentNode.removeChild(element);
            </script>
	
	
	<div id="primary" class="column collection548" style="width:95%">

            <div class="printLogo">
                <img src="http://g.fool.com/art/foollogo/horizontaltmf.gif" alt="The Motley Fool"/>
            </div>
		
		<div id="content" class="hentry cms" itemscope itemtype="http://schema.org/Article" style="width:590px; margin:0 auto; float:none;">

			
			<!--googleon:all-->
		        
		    <h1 class="xlHeader">Why I Bought Exelixis</h1>
		    
		    
	                

			
			<p class="articleMeta">
				<span class="vcard byline">By
				
					<a class="qsAdd qs-source-iapsitlnk0000002" href="http://my.fool.com/profile/tmfultralong/info.aspx"><span itemprop="author" content="Sean Williams">Sean Williams</span></a> <meta itemprop="contributor" content="1813" />
				
				|
				<a class="qsAdd qs-source-iapsitlnk0000003" href="/author/1813/index.aspx">More Articles</a>
				</span> 

				<br />
				<span class="dateline">April 4, 2014</span>
				|
				<span class="comments"><a href="#commentsBoxAnchor">Comments (4)
				</a></span>
			</p>

			<div class="entry-content">
		       
				

				

				<p>Some days as a biotech investor, no matter how savvy you think you are, you just have to bury your head in the sand because you're bound to experience a bad day. That's what happened last week to shareholders of <strong>Exelixis</strong>  (<span class="ticker">NASDAQ: <a data-id="203458" class="qsAdd qs-source-isssitthv0000001" href="http://caps.fool.com/Ticker/EXEL.aspx">EXEL</a></span>&nbsp;<a class="addToWatchListIcon qsAdd qs-source-iwlsitbut0000010" title="Add EXEL to My Watchlist" href="http://my.fool.com/watchlist/add?ticker=EXEL">&nbsp;</a>) , a company I've been very bullish on for more than a year which reported an uninspiring update to its phase 3 results for Cometriq (also known as cabozantinib) as a treatment for late-stage prostate cancer.</p>
<p>In a press release issued on Tuesday evening, Exelixis announced that the independent data monitoring committee overseeing its COMET-1 phase 3 trial involving Cometriq in metastatic castration-resistant prostate cancer (mCRPC) had <a href="http://www.fool.com/investing/general/2014/03/31/exelixis-continues-on.aspx">recommended the trial proceed to its final analysis</a>. Normally a trial proceeding is good news as it would signify the safety, tolerability, and potentially efficacy of an experimental therapy. However, with the metastatic prostate cancer field beginning to get crowded, this IDMC recommendation could signify that Cometriq doesn't offer a superior risk of death reduction compared to already existing therapies from <strong>Johnson &amp; Johnson</strong>  (<span class="ticker">NYSE: <a data-id="204142" class="qsAdd qs-source-isssitthv0000001" href="http://caps.fool.com/Ticker/JNJ.aspx">JNJ</a></span>&nbsp;<a class="addToWatchListIcon qsAdd qs-source-iwlsitbut0000010" title="Add JNJ to My Watchlist" href="http://my.fool.com/watchlist/add?ticker=JNJ">&nbsp;</a>) , <strong>Medivation</strong>  (<span class="ticker">NASDAQ: <a data-id="209613" class="qsAdd qs-source-isssitthv0000001" href="http://caps.fool.com/Ticker/MDVN.aspx">MDVN</a></span>&nbsp;<a class="addToWatchListIcon qsAdd qs-source-iwlsitbut0000010" title="Add MDVN to My Watchlist" href="http://my.fool.com/watchlist/add?ticker=MDVN">&nbsp;</a>)  and <strong>Astellas Pharma</strong>  (<span class="ticker">NASDAQOTH: <a data-id="270974" class="qsAdd qs-source-isssitthv0000001" href="http://caps.fool.com/Ticker/ALPMY.aspx">ALPMY</a></span>&nbsp;<a class="addToWatchListIcon qsAdd qs-source-iwlsitbut0000010" title="Add ALPMY to My Watchlist" href="http://my.fool.com/watchlist/add?ticker=ALPMY">&nbsp;</a>) , and <strong>Dendreon</strong>  (<span class="ticker">NASDAQ: <a data-id="203319" class="qsAdd qs-source-isssitthv0000001" href="http://caps.fool.com/Ticker/DNDN.aspx">DNDN</a></span>&nbsp;<a class="addToWatchListIcon qsAdd qs-source-iwlsitbut0000010" title="Add DNDN to My Watchlist" href="http://my.fool.com/watchlist/add?ticker=DNDN">&nbsp;</a>) . In other words, investors were looking for the trial to be stopped early due to strong efficacy.</p>
<p class="caption"><img alt="" src="http://g.foolcdn.com/editorial/images/115530/microscope_large.jpg"><br>Source: <a href="http://pixabay.com/en/people-scientist-microscope-white-219985/">PublicDomainPictures</a>, Pixabay.</p>
<p><strong>The risk<br> </strong>The most readily apparent risk from the continuation of this trial is that Cometriq won't be able to stand out in a crowded field of therapies.</p>
<p>Dendreon's immunotherapy vaccine Provenge is one later-stage option that did provide a four-month median survival benefit, but has failed to see sales take off due to its comparatively higher costs relative to Johnson &amp; Johnson's Zytiga and Medivation/Astellas' Xtandi. Zytiga not only cost less within a single year than Provenge, but it also offered a median overall survival benefit of 5.2 months relative to the placebo.</p>
<p>The real star, though, and Exelixis' main threat if approved, is Medivation &amp; Astellas Pharma's Xtandi which improved median overall survival in late-stage prostate cancer patients by 4.8 months versus the placebo. Furthermore, it also demonstrated <a href="http://www.fool.com/investing/general/2014/01/29/why-medivation-inc-shares-jumped.aspx">incredible efficacy</a> in its PREVAIL study in chemotherapy-naïve patients, reducing risk of death by 29% and delaying the initiation of chemotherapy in patients by a whopping 17.2 months over the placebo (28 months versus 10.8 months). In other words, if Medivation gains this new pre-chemo indication it could stand out as a great all-around therapy for later-stage prostate cancer patients.</p>
<p>In phase 2 studies involving cabozantinib in heavily pretreated men, median overall survival clocked in at 10.8 months – a respectable figure considering that 73% of the 144-patient population had received at least two prior therapies. Its study also noted a bone scan response (i.e., a greater than 30% decrease from baseline in lesion area as determined by CT scan) was observable in 65% of patients. The concern is if the IDMC wants the study to continue then its median OS is likely to be little changed from what Zytiga or Xtandi offer patients.</p>
<p>The advanced prostate cancer market is huge given that prostate cancer is the most diagnosed type of cancer in the United States, so meeting its primary endpoint but underperforming its peers could set Exelixis' Cometriq up for a very limited ceiling in mCRPC. With Cometriq being its only currently approved therapy for a rare type of thyroid cancer, pessimists believe that Exelixis' <a href="http://www.fool.com/investing/general/2014/03/28/exelixis-incs-comet-fails-to-dazzle.aspx">current revenue potential is capped</a>.</p>
<div class="image small imgR"><img alt="" src="http://g.foolcdn.com/editorial/images/115530/profit-loss_large.jpg" width="240">
<p class="caption">Source: <a href="http://pixabay.com/en/annual-report-stock-exchange-203760/">Geralt</a>, Pixabay.</p>
</div>
<p><strong>The opportunity (and why I bought Exelixis)<br> </strong>Despite Exelixis' tumble, which at one point equaled nearly half of the company's value in a four-day span, I decided to purchase the company for my own personal portfolio as I see a bright future for Cometriq and its overall pipeline.</p>
<p>Let's take things step-by-step and I'll show you why I'm so optimistic about Exelixis.</p>
<p>To begin with, we have the ongoing COMET-1 trial which I anticipate will demonstrate superior death risk reduction relative to the placebo (prednisone) in men with bone-dominant mCRPC who had progressed while using the combination of docetaxel and either Zytiga or Xtandi. Although it may not "stand out" per se, the drug itself should still see revenue on par, if not slightly better than Dendreon's Provenge which is also failing to stand out. Dendreon's drug is capable of approximately $400 million in peak sales, which I believe is a fair estimate worldwide if Cometriq is approved in mCRPC.</p>
<p>Second, we have Cometriq <a href="http://www.fool.com/investing/general/2013/04/28/tackling-cancer-thyroid-cancers-biggest-current-up.aspx">already approved</a> to treat metastatic medullary thyroid cancer by the FDA and just recently receiving EU clearance to market its therapy to MTC in Europe. Based on <a href="http://www.fool.com/investing/general/2013/01/14/jpmorgan-healthcare-conference-highlights-exelixis.aspx">company projections of roughly 500 to 700 patients in the U.S.</a>, and my own personal estimate of a similar amount in the EU, peak sales in this indication could total around $200 million at a price of $9,900 per month.</p>
<p>Added together, I already believe there's peak potential of $600 million if Cometriq gains the mCRPC indication inclusive of its U.S. and EU approval for MTC. Based on its current valuation of around $700 million we're looking at a company trading at just over one times peak sales. Given that we're seeing clinical-stage companies valued at three to five times annual peak sales estimates regularly, I have to believe either the entire market is overvalued or Exelixis is being brutally undervalued. Regardless of which one it is, further downside appears minimal in my opinion.</p>
<p>My other contention relates to its pipeline which is being largely discounted throughout this process. First, Cometriq is also being studied in two other phase 3 trials METEOR and CELESTIAL to study its effects against a placebo (usually a high-profile branded drug) in metastatic renal cell carcinoma and hepatocellular carcinoma patients who've received treatment with Nexavar. Why aren't investors giving these potentially life-altering studies any credit?  </p>
<p>In addition to other ongoing studies with Cometriq, Exelixis has a mountain of ongoing collaborations that range between preclinical and phase 2 in nature (nine studies altogether). The breakdown includes four therapies partnered with <strong>Bristol-Myers Squibb</strong>, two with <strong>Sanofi</strong>, and one each with <strong>Merck</strong>, <strong>GlaxoSmithKline</strong>, and <strong>Daiichi-Sankyo</strong>. The result is ample upfront cash from these collaborations and plenty of marketing firepower should these collaborative therapies be approved.</p>
<p>In sum, I believe we've seen a classic overreaction to modestly bad news from the COMET-1 trial and a complete disassociation from investors as to the potential of its remaining pipeline and partnerships. I'm now long Exelixis and hopeful that Cometriq's additional indications may help move the company's total annual revenue to more than $1 billion before the end of the decade.</p>
<p></p>
<div class="sfr" id="pitch">
  <p><strong>Exelixis may have a chance to soar once again, but even it could struggle to keep pace with this top stock<br></strong>There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special <em>free</em> report "<a href="http://www.fool.com/ecap/stock-advisor/sa-stocks2014-sfr/?aid=6915&amp;source=isaeditxt0900096">The Motley Fool's Top Stock for 2014</a>." Just <a href="http://www.fool.com/ecap/stock-advisor/sa-stocks2014-sfr/?aid=6915&amp;source=isaeditxt0900096">click here</a> to access the report and find out the name of this under-the-radar company.</p>
</div>                     <script type="text/javascript">                         var FoolAnalyticsData = FoolAnalyticsData || [];                           FoolAnalyticsData.push({                            eventType: "ArticlePitch",                            contentByline: "Sean Williams",                            contentId: "cms.115530",                            contentTickers: "",                            contentTitle: "Why I Bought Exelixis",                            hasVideo: "False",                            pitchId: "447",                            pitchTickers: "",                            pitchTitle: "",                            pitchType: "sfr",                            sfrId: ""                         });                     </script>                     <p></p>
				

<script type="text/javascript" src="http://j.foolcdn.com/common/js/marketing/pitchengine.js?v=82515"></script>


<div id="pitcherPitch">
</div>
 
<script>
    Fool.onContent(function() {
        var pitchEngine = PitchEngine();
        var pitchId = -1;
        var sessionCount = 1;
        var firstPageView = 0;

        if (typeof (FoolAnalyticsData) !== "undefined" && typeof (FoolAnalyticsData[0]) !== "undefined" && typeof (FoolAnalyticsData[0].pitchId) !== "undefined") {
            pitchId = FoolAnalyticsData[0].pitchId;
        }

        if (Fool.Cookie.exists('Visitor')) {
            var visitCountCookie = Fool.Cookie.getValues('Visitor')['visits'];
            if (typeof(visitCountCookie) !== "undefined") {
                sessionCount = pitchEngine.tryParseInt(visitCountCookie, 1); 
            }
        }

        var dataTracker = FoolPitchEngineTracker();
        dataTracker.initialize(window.dataLayer);

        pitchEngine.initialize(dataTracker, {
            site: 'fool',
            tickers: 'EXEL,ALPMY,DNDN,JNJ,MDVN',
            instrumentId: '203458,270974,203319,204142,209613',
            uid: '0',
            guid: '',
            isEcapped: false,
            isBuyer: false,
            containsPitchBase: false,
            productId: '',
            pitchId: pitchId,
            sessionCount: sessionCount,
            firstPageview: firstPageView,
            skin: ''
        });
    });
</script>

						

				<!-- surphace end -->
				
				<!-- Third Party Content Additional Links (if any).  XML path and visibility is set according to Provider in code-behind -->
				


				
        		
        		
				
				
				
					
				<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=1;seg=default;src=;sz=5x7;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=1;seg=default;src=;sz=5x7;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=1;seg=default;src=;sz=5x7;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript><div class='footer'><p><em><em><a href="mailto:swilliams@Fool.com">Sean Williams</a> owns shares of Exelixis, but has no material interest in any other companies mentioned in this article. You can follow him on CAPS under the screen name <a href="http://caps.fool.com/player/tmfultralong.aspx">TMFUltraLong</a>, track every pick he makes under the screen name <a href="http://caps.fool.com/player/trackultralong.aspx">TrackUltraLong</a>, and check him out on Twitter, where he goes by the handle <a href="http://twitter.com/#%21/TMFUltraLong">@TMFUltraLong</a>.</em></em></p>
<p><em>The Motley Fool owns shares of, and recommends Exelixis and Johnson &amp; Johnson. Try any of our Foolish newsletter services <a href="http://www.fool.com/shop/newsletters/index.aspx?source=isiedilnk018048">free for 30 days</a>. We Fools may not all hold the same opinions, but we all believe that <a href="http://wiki.fool.com/Motley">considering a diverse range of insights</a> makes us better investors. The Motley Fool has a <a href="http://www.fool.com/Legal/fool-disclosure-policy.aspx">disclosure policy</a>.</em></p></div>
			
			</div><!-- /entry-content -->
					
		</div><!-- /content -->
		<br style="clear:both;" />
        

		
        
            <center><div style="max-width: 590px; text-align: left">
            <div class="promoboxAd">
			    <script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=3;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=3;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=470x300;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=3;ord=4019766?" border="0" alt=""></a></noscript>
		    </div>
            </div></center>
        
        
        
		<div id="articleTools">

			<p id="recModuleBottom">				
			  <span class="readComments"><a href="#commentsBoxAnchor">Read/Post Comments (4)</a></span>
				<span class="recModulePike"> | </span>
				<span class="recArticle">
	<span class="recInline">
		<a href="#" onclick="Recommendations.RecommendIt('0','2899475','Post', this);return false;">Recommend This Article (10)</a> 
	</span>
	<noscript>
		<span class="recInline">
			Recommended 10 Times
		</span>
  </noscript>


</span>
                
				<!-- AddThis Button BEGIN --> 
				<div class="shareLinks clearfix addthis_toolbox" id="horizontal_bottom_toolbox" >
					<a class="addthis_button_facebook_like" fb:like:layout="button_count"></a>
					<a class="addthis_button_tweet" tw:via="themotleyfool"></a>
					<!--<a class="addthis_button_google_plusone" g:plusone:size="medium"></a>-->
					<a class="addthis_button_email email_bg">Email</a>
					<a class="print_bg" href="/server/FoolPrint.asp?File=/investing/general/2014/04/04/why-i-bought-exelixis.aspx">Print</a>
					<a class="feedback_bg" href="http://www.fool.com/Help/Index.htm?display=EmailNews&amp;p=/investing/general/2014/04/04/why-i-bought-exelixis.aspx">Feedback</a>
                    <a class="addthis_counter addthis_pill_style"></a>
                    <script type="text/javascript"> var addthis_config = { "data_track_addressbar": true };</script>

				</div>	
				<script src="http://s7.addthis.com/js/250/addthis_widget.js#pubid=ra-4fccc73f4f57fb0a" type="text/javascript"></script>

			
			</p>
        
        	<!-- AddThis VERTICAL Buttons BEGIN -->
				<div class="addthis_toolbox addthis_floating_style addthis_counter_style"  id="vertical_toolbox">
					<a class="addthis_button_facebook_like" fb:like:layout="box_count"></a>
					<a class="addthis_button_tweet" tw:count="vertical" tw:via="themotleyfool"></a>
					<!--<a class="addthis_button_google_plusone" g:plusone:size="tall"></a>-->
                    <a class="addthis_button_linkedin_counter" li:counter="top"></a>
					<a class="addthis_button_email email_bg">Email</a>
					<a class="addthis_button_print print_bg">Print</a>
				</div>
               


		</div><!-- /articleTools -->

		<div class="component" id="articleCommentsAjaxContainer">
			

<input type="hidden" name="ArticleID" id="ArticleID" value="2899475"/> 

<div id="comments">
	<a name="commentsBoxAnchor" id="commentsBoxAnchor"></a>
	<h3 class="boxTop">Comments from our Foolish Readers</h3>
	<p class="intro"><strong>Help us keep this a respectfully Foolish area!</strong> This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above.  Help us keep it clean and safe.  If you believe a comment is abusive or otherwise violates our <a href="http://www.fool.com/help/index.htm?display=newuser02">Fool's Rules</a>, please report it via the <img src="//g.foolcdn.com/art/article/icn_comment-redhand.gif" alt="Report this Comment" /> <strong>Report this Comment</strong> icon found on every comment.</p>

	<div id="ajaxPosts">
		
			<ul id="commentsList" class="truncated">
				
						<li id="comment954103">
							<div class="commentHead">
								<h6>
									<a href="#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
									On April 04, 2014,
									at 1:19 PM, 
									<a href="http://boards.fool.com/Profile.asp?uid=1759452819"><strong>usfarbuo</strong></a> wrote:
								</h6>
							</div>
							<div class="commentPost"><p><p rel="nofollow">I'm sure hoping you are right on this one. I'm on board with exel but I sure have my doubts the last two weeks. Can't believe it has not bounced </p><p rel="nofollow">Back from last week.</p><p rel="nofollow">Good luck to both of us.</p></p></div>
								
						</li>
					
						<li id="comment954112">
							<div class="commentHead">
								<h6>
									<a href="#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
									On April 04, 2014,
									at 2:05 PM, 
									<a href="http://boards.fool.com/Profile.asp?uid=203288397"><strong>bhukaplan</strong></a> wrote:
								</h6>
							</div>
							<div class="commentPost"><p><p rel="nofollow">It is stunning to me how limited is the insight of the street on what is really going on. Let me, an experienced practicing oncologist explain: Provenge has a problem. It is complicated to use requiring harvesting of T cells and then sensitizing them with 3 visits to for example the NY Blood Center and there are no objective benefits. Xtandi and Abiraterone are excellent drugs but both have the same target and there is little or no evidence that when one fails the other will work. It is extremely unlikely so it is one treatment and while good palliation will not cure these patients who eventually develop total androgen independence. Radon irradiation is complicated with the patients requiring semi isolation for a few days. Hard to arrange and does not treat non bone lesions. Finally, in this population it would have been a near miracle for the interim analysis to have been positive. Look back at the exelexis board from months ago for an explanation. The street's reaction is thoroughly stupid. If Cabo works it will displace both Taxotere and Jevtana further down the road. There is plenty of need for this drug and an awful lot of very good scientists are involved in the trials.  I own shares and am biased. I am also right</p></p></div>
								
						</li>
					
						<li id="comment954201">
							<div class="commentHead">
								<h6>
									<a href="#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
									On April 04, 2014,
									at 7:15 PM, 
									<a href="http://boards.fool.com/Profile.asp?uid=258228850"><strong>Pietrocco</strong></a> wrote:
								</h6>
							</div>
							<div class="commentPost"><p><p rel="nofollow">Sean,</p><p rel="nofollow">You did not mention the very important combo with Roche!!</p><p rel="nofollow">That alone is worth at least several hundred million dollars!</p><p rel="nofollow">Why didn`t you include it??</p></p></div>
								
						</li>
					
						<li id="comment954279">
							<div class="commentHead">
								<h6>
									<a href="#" title="Report this Comment" class="foolcop redflag"><span>Report this Comment</span></a>
									On April 05, 2014,
									at 3:02 AM, 
									<a href="http://boards.fool.com/Profile.asp?uid=152690069"><strong>usubanas</strong></a> wrote:
								</h6>
							</div>
							<div class="commentPost"><p><p rel="nofollow">Pietrocco,</p><p rel="nofollow">Sean didn't mention cobimetinib phase 3 because his understanding of Exelixis is very limited. But he'll probably be happy to find out.</p><p rel="nofollow">He got the pc indication totally wrong. Cabo is for 3rd line, not expected to compete with Zytiga, Ztandi or Provenge.</p></p></div>
								
						</li>
					
			</ul>
				<a name="newCommentAnchor" id="newCommentAnchor"></a>
			<h5>Add your comment.</h5>
		
	
		
	</div>

	

	

	
	
		<div id="newComment" class="addNew commentTools" style="display:none">
			<p id="P1">
				Your Fool username<!-- of <strong>insert username here</strong>--> will be displayed with your comment.<br /><br />
				Please be respectful with your comments. Review our <a href="http://www.fool.com/help/index.htm?display=newuser02">Fool's Rules</a>.
			</p>
			<textarea name="txtBody" rows="12" cols="30" id="txtBody" class="textbox" onclick="Fool.Authenticate(null, function() { $('txtBody').readOnly=false; })" readonly="readonly"></textarea>
			<p class="small muted">Your comment may be delayed up to 15 minutes</p>
			<div class="buttons">
				<input type="button" id="btnSave" class="nl-button call-to-action" value="Post Your Comment" onclick="ArticleComments.doSave()" /> 
			</div>
		</div> 
	

	<script type="text/javascript">
		document.observe("dom:loaded", function () {
			ArticleComments.showTools();
		});
	</script>
	<noscript>
		<div id="jsWarning">
			<p>Javascript is required to comment on Fool articles.</p>
		</div>
	</noscript>
</div>






















		</div>
		<!--googleoff:all-->
		
<div class="compareBrokersAds">
	<h3 class="boxTop"><a href="/how-to-invest/broker/index.aspx?source=ifldbcdbx0000002">Compare Brokers</a></h3>
	<div class="compareBrokersBox">
		<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_1;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript>
	</div>
	<div class="compareBrokersBox INGCompare">
		<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_2;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript>
	</div>
	<div class="compareBrokersBox">
		<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_3;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript>
	</div>
	<div class="compareBrokersBox">
		<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=hlp_4;seg=default;src=;sz=88x31;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript>
	</div>
	<a href="/how-to-invest/broker/disclosure.aspx?source=compare" class="disclosure">Fool Disclosure</a>
</div>
		

<div class="sponsoredLinksAd">
        <span style="font-size:10pt"><a href="http://www.fool.com/ecap/stock-advisor/sa-web-goes-dark/?aid=7126&amp;source=esazactxt0860023" target="_blank"><b> R.I.P. Internet -- 1969-2014</b></a><br>
        At only 45 years old... the Internet will be laid to rest in 2014. And Silicon Valley is thrilled. Because they know... The Economist believes the death of the Internet "will be transformative." In fact, the CEO of Cisco Systems -- one of the largest tech companies on the planet -- says somebody's going to bank "14.4 trillion in profit from one concept alone." 
        <a href="http://www.fool.com/ecap/stock-advisor/sa-web-goes-dark/?aid=7126&amp;source=esazactxt0860023" target="_blank">Click here for a FREE video that gives you what you need to capitalize on the little-known company behind this concept.</a></span></td>
</div>

		<p class="debug">DocumentId: 2899475, ~/Articles/ArticleHandler.aspx, 4/7/2014 1:13:58 PM</p>
		<!-- do not remove this comment - articlescontent -->
		
	</div><!-- /primary -->

	

<fieldset id="foolcop">

	<h3>Report This Comment</h3>

	<p>
		Use this area to report a comment that you believe 
		is in violation of the community guidelines. Our 
		team will review the entry and take any appropriate 
		action.
	</p>

	<input type="hidden" name="whichComment" id="whichComment" value="" />
	<input type="hidden" name="commentContent" id="commentContent" value="" />

	<textarea name="reporterNote" id="reporterNote" rows="4" cols="18"></textarea>

	<div class="buttons">
		<input class="button" name="reportToFoolCop" id="reportToFoolCop" type="submit" value="Send this Report" />
		<input class="button" name="cancelFoolCop" id="cancelFoolCop" type="submit" value="Cancel" />
	</div>
</fieldset>

<div id="progress-indicator">

	<img alt="" src="http://g.foolcdn.com/art/newsletters/22/site/icn_progress.gif" />

	<h3>Sending report...</h3>

</div>

	
	
	<!-- AdA.Master -->
	<!--googleoff:all-->
	<div id="secondary" style="display:none;">
        
        
        <div class="round clearfix">
			

<div id="relatedTickers" class="component round">
	<h3>
		Related Tickers
	</h3>
	<div class="timestamp">
		4/7/2014 12:48 PM
	</div>

    
    <table class="tableNaked relatedTicker" cellpadding="0" cellspacing="0" itemscope="itemscope" itemtype="http://schema.org/Intangible/FinancialQuote">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
				    <meta itemprop="id" content="203458" />
				    <meta itemprop="exchange" content="NASDAQ" />
				    <meta itemprop="tickerSymbol" content="EXEL" />
                    <meta itemprop="url" content="http://caps.fool.com/ticker/EXEL.aspx" />
					<a href="http://caps.fool.com/ticker/EXEL.aspx" class="qsAdd qs-source-irlsitlnk0000001 qs-lidx-1">EXEL</a>
				</td>
				<td class="currentPrice">
				    <meta itemprop="price" content="3.61" />
					$3.61
				</td>
				<td class="movementDirection">
					<img src="http://g.foolcdn.com/common/img/ico/arrows/arrow_Down_medium.png" height="13" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
				    <meta itemprop="priceChange" content="-0.01" />
					-0.01
				</td>
				<td class="pricePercentChange neg">
				    <meta itemprop="priceChangePercent" content="-0.25" />
					-0.25%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Exelixis
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="http://g.foolcdn.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>


    
    <table class="tableNaked relatedTicker" cellpadding="0" cellspacing="0" itemscope="itemscope" itemtype="http://schema.org/Intangible/FinancialQuote">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
				    <meta itemprop="id" content="270974" />
				    <meta itemprop="exchange" content="NASDAQOTH" />
				    <meta itemprop="tickerSymbol" content="ALPMY" />
                    <meta itemprop="url" content="http://caps.fool.com/ticker/ALPMY.aspx" />
					<a href="http://caps.fool.com/ticker/ALPMY.aspx" class="qsAdd qs-source-irlsitlnk0000001 qs-lidx-2">ALPMY</a>
				</td>
				<td class="currentPrice">
				    <meta itemprop="price" content="11.51" />
					$11.51
				</td>
				<td class="movementDirection">
					<img src="http://g.foolcdn.com/common/img/ico/arrows/arrow_Down_medium.png" height="13" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
				    <meta itemprop="priceChange" content="-0.09" />
					-0.09
				</td>
				<td class="pricePercentChange neg">
				    <meta itemprop="priceChangePercent" content="-0.78" />
					-0.78%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					ASTELLAS PHARMA UN&#8230;
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="No stars" 
						src="http://g.foolcdn.com/art/ratings/foolcaps_lrg_none.gif" 
						class="infoTip" 
						title="Unrated" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>


    
    <table class="tableNaked relatedTicker" cellpadding="0" cellspacing="0" itemscope="itemscope" itemtype="http://schema.org/Intangible/FinancialQuote">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
				    <meta itemprop="id" content="203319" />
				    <meta itemprop="exchange" content="NASDAQ" />
				    <meta itemprop="tickerSymbol" content="DNDN" />
                    <meta itemprop="url" content="http://caps.fool.com/ticker/DNDN.aspx" />
					<a href="http://caps.fool.com/ticker/DNDN.aspx" class="qsAdd qs-source-irlsitlnk0000001 qs-lidx-3">DNDN</a>
				</td>
				<td class="currentPrice">
				    <meta itemprop="price" content="2.77" />
					$2.77
				</td>
				<td class="movementDirection">
					<img src="http://g.foolcdn.com/common/img/ico/arrows/arrow_Down_medium.png" height="13" width="17" alt="Down" />
				</td>
				<td class="priceChange neg">
				    <meta itemprop="priceChange" content="-0.07" />
					-0.07
				</td>
				<td class="pricePercentChange neg">
				    <meta itemprop="priceChangePercent" content="-2.46" />
					-2.46%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Dendreon Corp
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="**" 
						src="http://g.foolcdn.com/art/ratings/foolcaps_lrg_two.gif" 
						class="infoTip" 
						title="2 Stars: Unattractive" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>


    
    <table class="tableNaked relatedTicker" cellpadding="0" cellspacing="0" itemscope="itemscope" itemtype="http://schema.org/Intangible/FinancialQuote">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
				    <meta itemprop="id" content="204142" />
				    <meta itemprop="exchange" content="NYSE" />
				    <meta itemprop="tickerSymbol" content="JNJ" />
                    <meta itemprop="url" content="http://caps.fool.com/ticker/JNJ.aspx" />
					<a href="http://caps.fool.com/ticker/JNJ.aspx" class="qsAdd qs-source-irlsitlnk0000001 qs-lidx-4">JNJ</a>
				</td>
				<td class="currentPrice">
				    <meta itemprop="price" content="98.50" />
					$98.50
				</td>
				<td class="movementDirection">
					<img src="http://g.foolcdn.com/common/img/ico/arrows/arrow_Up_medium.png" height="13" width="17" alt="Up" />
				</td>
				<td class="priceChange pos">
				    <meta itemprop="priceChange" content="+0.08" />
					+0.08
				</td>
				<td class="pricePercentChange pos">
				    <meta itemprop="priceChangePercent" content="+0.08" />
					+0.08%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Johnson & Johnson
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="****" 
						src="http://g.foolcdn.com/art/ratings/foolcaps_lrg_four.gif" 
						class="infoTip" 
						title="4 Stars: Favorite" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>


    
    <table class="tableNaked relatedTicker" cellpadding="0" cellspacing="0" itemscope="itemscope" itemtype="http://schema.org/Intangible/FinancialQuote">
		<tbody>
			<tr class="priceInfo">
				<td class="ticker">
				    <meta itemprop="id" content="209613" />
				    <meta itemprop="exchange" content="NASDAQ" />
				    <meta itemprop="tickerSymbol" content="MDVN" />
                    <meta itemprop="url" content="http://caps.fool.com/ticker/MDVN.aspx" />
					<a href="http://caps.fool.com/ticker/MDVN.aspx" class="qsAdd qs-source-irlsitlnk0000001 qs-lidx-5">MDVN</a>
				</td>
				<td class="currentPrice">
				    <meta itemprop="price" content="60.96" />
					$60.96
				</td>
				<td class="movementDirection">
					<img src="http://g.foolcdn.com/common/img/ico/arrows/arrow_Up_medium.png" height="13" width="17" alt="Up" />
				</td>
				<td class="priceChange pos">
				    <meta itemprop="priceChange" content="+0.93" />
					+0.93
				</td>
				<td class="pricePercentChange pos">
				    <meta itemprop="priceChangePercent" content="+1.55" />
					+1.55%
				</td>
			</tr>
			<tr>
				<td class="companyName" colspan="2">
					Medivation, Inc.
				</td>
				<td class="capsRating" colspan="3">
				<span class="capsRating">
					CAPS Rating: 
					<img
						alt="**" 
						src="http://g.foolcdn.com/art/ratings/foolcaps_lrg_two.gif" 
						class="infoTip" 
						title="2 Stars: Unattractive" />
				</span>
				</td>
			</tr>
		</tbody>
	</table>



</div>


		</div>

	</div><!-- /secondary -->
	<!--googleon:all-->
	<!-- /AdA.Master -->

	<!-- /ArticlesContent.Master -->
    <div id="informTickerReportAd"></div>

        </div>

		</div>
	</div>

		
		<!--googleoff: all--><br clear="all"><div id="footer">
  <div class="grid">
    <div class="column span-25">
      <ul>
        <li class="first"><a href="http://www.fool.com/" class="qsAdd qs-source-ihpftrlnk0000001" title="Home">Home</a></li>
        <li><a href="http://www.fool.com/Press/History.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="About The Motley Fool">About The Motley Fool</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=about02&amp;ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Fool Disclosure">Fool Disclosure</a></li>
        <li><a href="http://wiki.fool.com/Motley_Fool_Money_Radio_Show" class="qsAdd qs-source-ihpftrlnk0000001" title="Radio Show">Radio Show</a></li>
        <li><a href="http://www.fool.com/Jobs/?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Work at The Fool">Work at The Fool</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=about01&amp;ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Member Services">Member Services</a></li>
      </ul>
      <ul>
        <li class="first"><a href="http://www.fool.com/legal/contact-us.aspx" class="qsAdd qs-source-ihpftrlnk0000001" title="Advertise with The Fool">Advertise with The Fool</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=newuser03" class="qsAdd qs-source-ihpftrlnk0000001" title="Privacy Policy">Privacy Policy</a></li>
        <li><a href="http://www.fool.com/Account/Freemailsubscribe.aspx?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Email Subscriptions">Email Subscriptions</a></li>
        <li><a href="http://www.fool.com/about/headlines/rss.htm?ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="RSS Headlines"><img alt="RSS" class="rssLogo" src="http://g.foolcdn.com/img/rss.gif"> RSS Headlines</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=default&amp;ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Help">Help</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=morehelp01&amp;ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Site Map">Site Map</a></li>
        <li><a href="http://www.fool.co.uk/" class="qsAdd qs-source-ihpftrlnk0000001" title="Fool UK"><img alt="Fool UK" class="foolUkLogo" src="http://g.foolcdn.com/img/uk.gif"> Fool UK</a></li>
      </ul>
      <ul id="foolFriends">
        <li class="first">Fool Friends: </li>
        <li class="first"><a rel="nofollow" href="http://finance.yahoo.com/" target="_blank" title="Yahoo Finance">Yahoo Finance</a></li>
        <li><a rel="nofollow" href="http://www.money.msn.com/" target="_blank" title="MSN Money">MSN Money</a></li>
        <li><a rel="nofollow" href="http://www.dailyfinance.com/" target="_blank" title="AOL Business News">AOL Business News</a></li>
        <li><a href="http://www.mint.com/" target="_blank" title="Mint">Mint Personal Finance Software</a></li>
        <li><a href="http://www.lovemoney.com/" target="_blank" title="lovemoney.com">lovemoney.com</a></li>
      </ul>
      <ul id="legal">
        <li class="first"><a href="http://www.fool.com/help/index.htm?display=about03&amp;ref=BTMP" class="qsAdd qs-source-ihpftrlnk0000001" title="Copyright, Trademark and Patent Information">Copyright, Trademark and Patent Information</a></li>
        <li><a href="http://www.fool.com/help/index.htm?display=newuser02" title="Terms of Use">Terms of Use</a>
							© 1995 -
							2014
							The Motley Fool. All rights reserved.
                    	</li>
      </ul>
    </div><br><p class="attrib xMarginT flushB">
					BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.<br>
					Real-Time prices provided by <a href="http://www.batstrading.com/" target="_blank">BATS</a>. Market data provided by <a href="http://www.interactivedata.com/" target="_blank">Interactive Data</a>.<br>
					Company fundamental data provided by <a href="http://fundamentals.morningstar.com/" target="_blank">Morningstar</a>. Earnings Estimates and Analyst Ratings provided by <a href="http://www.zacks.com/" target="_blank">Zacks</a>.<br>
					SEC Filings and Insider Transactions provided by Edgar Online.<br>
					Powered and implemented by <a href="http://www.interactivedata.com/idms/" target="_blank">Interactive Data Managed Solutions</a>. <a href="javascript:void(0);" onclick="javascript:var win = window.open('http://caps.fool.com/idcterms.htm', '','width=400,height=300,status=0,resizable=yes,scrollbars=yes');return false;" title="Interactive Data Terms &amp; Conditions. Opens in a new browser window.">Terms &amp; Conditions</a><br><a href="http://www.interactivedata.com/" target="_blank"><img alt="Interactive Data" class="idcLogo" src="http://g.foolcdn.com/img/topNav/idc.gif"></a></p>
  </div>
  <div id="fn-serverinfo">47ms USEQ\WEB23
<!-- do not remove this comment --><!-- size mapping  failed --></div><script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=13;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=13;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=3x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=13;ord=4019766?" border="0" alt=""></a></noscript><script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=;seg=default;src=;sz=1x5;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=;seg=default;src=;sz=1x5;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=;seg=default;src=;sz=1x5;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript></div><script type="text/javascript">
			var _gaq = _gaq || [];
			_gaq.push(['_setAccount', 'UA-3262475-1']);
			_gaq.push(['_trackPageview']);

			(function() {
			var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
			ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
			var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
			})();
		</script><script type="text/javascript">_qacct = "p-77sCb6T55qLV6";</script><script type="text/javascript" src="http://secure.quantserve.com/quant.js"></script><noscript><a href="http://www.quantcast.com/p-77sCb6T55qLV6" target="_blank"><img style="display: none;" border="0" height="1" width="1" alt="Quantcast" src="http://secure.quantserve.com/pixel/p-77sCb6T55qLV6.gif"></a></noscript><script type="text/javascript">var tcdacmd="dt";</script><script src="http://an.tacoda.net/an/18382/slf.js" type="text/javascript"></script><script type="text/javascript">
			// 
			(function () {
				var d = new Image(1, 1);
				d.onerror = d.onload = function () {
					d.onerror = d.onload = null;
				};
				d.src = ["//secure-us.imrworldwide.com/cgi-bin/m?ci=us-503335h&cg=0&cc=1&si=", escape(window.location.href), "&rp=", escape(document.referrer), "&ts=compact&rnd=", (new Date()).getTime()].join('');
			})();
			// 
		</script><noscript>
  <div><img src="//secure-us.imrworldwide.com/cgi-bin/m?ci=us-503335h&amp;cg=0&amp;cc=1&amp;ts=noscript" width="1" height="1" alt=""></div>
</noscript><!--googleon: all-->
		
	
	
	<script src="/common/js/fool/analytics.js"></script>
    
    <div id="fb-root"></div>
    <script type="text/javascript">
    	window.fbAsyncInit = function() {
    		FB.init({
    			appId: '50808187550',
    			status: true, // check login status
    			cookie: true, // enable cookies to allow the server to access the session
    			xfbml: true,  // parse XFBML
    			oauth: true
    		});
    		FB.Event.subscribe('edge.create', function(targetUrl) { // ga subscribe to likes
    			_gaq.push(['_trackSocial', 'facebook', 'like', targetUrl]);
    		});
    		FB.Event.subscribe('edge.remove', function(targetUrl) { // ga subscribe to unlikes
    			_gaq.push(['_trackSocial', 'facebook', 'unlike', targetUrl]);
    		});
    	};
    	(function() {
    		var e = document.createElement('script');
    		e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js';
    		e.async = true;
    		document.getElementById('fb-root').appendChild(e);
    	} ()); 
    </script>
			       

	
		    
			 <div id="ticklePrefixTemplate" style="display:none" class="txtC ruledT ruledB hPaddedB hPaddedT hMarginB hMarginT topTickle small"><strong><span class="muted"><span class="uppercase">Article Preview</span> &mdash; For full access, </span><a href="#lastVisibleParagraph">register below, it's free</a></strong></div>
             <div style="display:none" class="txtC big xMarginT xMarginB" id="bottomTickle"><span class="title"><strong>To keep reading, <a href="/Landing/TMF/Registration.aspx?dest=#{articleUrl}" class="popReg">click here, it's free</a> or <a class="popLogin" href="/secure/login.aspx?returnUrl=#{articleUrl}">login here</a></strong></span><div id="bottomTickleFrame"><iframe src="/common/ecap/tickle.aspx?source=#{sourceCode}&returnUrl=#{articleUrl}" width="100%" height="100%" id="tickle"></iframe></div></div>
		
			<script type="text/javascript">
			    Fool.onContent(function () { if (Article.Tickle) { Tickle = new Article.Tickle(); Tickle.setCellId(1); } });
		    </script>
		<script language="JavaScript" type="text/javascript" src="http://ad.doubleclick.net/adj/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?"></script><noscript><a href="http://ad.doubleclick.net/jump/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" rel="nofollow" target="_blank"><img src="http://ad.doubleclick.net/ad/usmf.inv.investing/articles;pos=overlay;seg=default;src=;sz=1x3;sub=default;port=default;trades=default;reg=false;uid=0;etfticker=false;ret=default;mgr=default;funds=default;goldticker=false;bureau=health-care;ord_aband=default;series=default;buckettarget=default;swap=false;sessionCount=1;tenOrMoreSessions=false;type=269;adtags=dividends,dow-article-series,growth,health-care,pharma,tech;tickers=JNJ,ALPMY,EXEL,MDVN,DNDN;tile=0;ord=4019766?" border="0" alt=""></a></noscript>


	

	
	<script type="text/javascript" src="https://apis.google.com/js/plusone.js"></script>
    
        <!-- AddThis Welcome BEGIN -->
    <script type="text/javascript" src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-4fccc73f4f57fb0a"></script>
    <script type='text/javascript'>
    	addthis.bar.initialize({
    		'default': {
    			"backgroundColor": "#E5EBF9",
    			"buttonColor": "#efefef",
    			"textColor": "#222222",
    			"buttonTextColor": "#444444"
    		}, rules: [
    			{
    				"name": "Twitter returning",
    				"match": { "referringService": "twitter", "returning": true },
    				"message": "If you find this article interesting:",
    				"action": {
    					"type": "button",
    					"text": "Tweet it!",
    					"verb": "share",
    					"service": "twitter"
    				}
    			},
    			{
    				"name": "Twitter new",
    				"match": { "referringService": "twitter", "returning": false },
    				"message": "We're on Twitter! Follow us on Twitter for your daily dose of Foolishness.",
    				"action": {
    					"type": "button",
    					"text": "Follow @themotleyfool",
    					"verb": "follow",
    					"service": "twitter",
    					"id": "themotleyfool"
    				}
    			},
    			{
    				"name": "Facebook returning",
    				"match": { "referringService": "facebook", "returning": true },
    				"message": "If you enjoyed the article, consider sharing it!",
    				"action": {
    					"type": "button",
    					"text": "Share on Facebook",
    					"verb": "share",
    					"service": "facebook"
    				}
    			},
    			{
    				"name": "Facebook new",
    				"match": { "referringService": "facebook", "returning": false },
    				"message": "We’re on Facebook! Like The Motley Fool on Facebook for your daily dose of Foolishness.",
    				"action": {
    					"type": "button",
    					"text": "Like The Motley Fool",
    					"verb": "like",
    					"service": "facebook",
    					"id": "themotleyfool"
    				}
    			},
    			{
    				"name": "linkedin",
    				"match": { "referringService": "linkedin" },
    				"message": "If you enjoyed this article, share it",
    				"action": {
    					"type": "button",
    					"text": "on LinkedIn",
    					"verb": "share",
    					"service": "linkedin"
    				}
    			},
    			{
    				"name": "stumbleupon",
    				"match": { "referringService": "stumbleupon" },
    				"message": "If you enjoy this article, do us a favor:",
    				"action": {
    					"type": "button",
    					"text": "Post on StumbleUpon",
    					"verb": "share",
    					"service": "stumbleupon"
    				}
    			}
    		]
    	});
    </script>
    <!-- AddThis Welcome END -->
   

    <!-- AddThis Google Analytic Tracking BEGIN -->
    <script type="text/javascript">
    	var addthis_config = {
    		data_ga_property: 'UA-3262475-1',
    		data_ga_social: true
    	}; 
    </script>
    	
    <!-- AddThis Google Analytic Tracking END -->
    
    <!-- GA Remarketing Pixels -->
    <script type="text/javascript">
        /* <![CDATA[ */
    	var google_conversion_id = 1069646824;
    	var google_conversion_label = "Ua-NCL7h6QUQ6IeG_gM";
    	var google_custom_params = {
    		STOCK_tckr : ['EXEL','ALPMY','DNDN','JNJ','MDVN'],
    		FIN_interest : 'INVEST',
    	};
    	var google_remarketing_only = true;
    /* ]]> */
    </script>

    <script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js"></script>

    <noscript>
        <div style="display:inline;">
            <img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/1069646824/?value=0&amp;label=Ua-NCL7h6QUQ6IeG_gM&amp;guid=ON&amp;script=0"/>
        </div>
    </noscript> 
   		
    

	
	<script type="text/javascript">
	    (function() {
	        var nc = document.createElement('script'); nc.type = 'text/javascript'; nc.async = true;
	        nc.src = 'http://scripts.verticalacuity.com/vat/mon/vtw.js';
	        var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(nc, s);
	    })();
	</script>

	<!-- START Parse.ly Include: Standard -->
	<div id="parsely-root" style="display: none">
	  <div id="parsely-cfg" data-parsely-site="fool.com"></div>
	</div>
	<script>
	    (function(s, p, d) {
	        var h=d.location.protocol, i=p+"-"+s,
	            e=d.getElementById(i), r=d.getElementById(p+"-root"),
	            u=h==="https:"?"d1z2jf7jlzjs58.cloudfront.net"
	                :"static."+p+".com";
	        if (e) return;
	        e = d.createElement(s); e.id = i; e.async = true;
	        e.src = h+"//"+u+"/p.js"; r.appendChild(e);
	    })("script", "parsely", document);
	</script>
	<!-- END Parse.ly Include -->

	<script data-main="http://j.foolcdn.com/js/main.js" src="http://h.foolcdn.com/tmfstatic/js/vendor/require.js" type="text/javascript"></script>

		
<div style="position:absolute;bottom:0;right:0;">
	<a href="http://at.atwola.com/adlink/3.0/5113.1/221794/0/-1/size=3x2;noperf=1;alias=93317647;kvmn=93317647;kvpg=www.fool.com%2finvesting%2fgeneral%2f2014%2f04%2f04%2fwhy;kvugc=0;grp=288470508;misc=288470508" target="_blank">
		<img src="http://at.atwola.com/adserv/3.0/5113.1/221794/0/-1/size=3x2;noperf=1;alias=93317647;kvmn=93317647;kvpg=www.fool.com%2finvesting%2fgeneral%2f2014%2f04%2f04%2fwhy;kvugc=0;grp=288470508;misc=288470508" width="3" height="2" border="0" alt="Advertisement" />
	</a>
</div>

        <script type="text/javascript">
            jQuery(window).load(function () {
                var pitcherAds = pitcherAds || PitcherAds();
                pitcherAds.OnDomReady();
                
                if (typeof(LeadspendValidation) !== "undefined" && jQuery('#ecapWidget_email').size() > 0) {
                    var leadspend = LeadspendValidation();
                    leadspend.run('#ecapWidget_email');
                }
            });
        </script>
	<script type="text/javascript">
//<![CDATA[
(function() {
var _analytics_scr = document.createElement('script');
_analytics_scr.type = 'text/javascript'; _analytics_scr.async = true; _analytics_scr.src = '/_Incapsula_Resource?SWJIYLWA=2977d8d74f63d7f8fedbea018b7a1d05&ns=1';
var _analytics_elem = document.getElementsByTagName('script')[0]; _analytics_elem.parentNode.insertBefore(_analytics_scr, _analytics_elem);
})();
// ]]>
</script></body>

	
	
	
	
	<!-- Content Reminders -->




</html>
